Literature DB >> 21998054

Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults.

Evan L Thacker1, Bruce M Psaty, Barbara McKnight, Susan R Heckbert, W T Longstreth, Kenneth J Mukamal, James B Meigs, Ian H de Boer, Edward J Boyko, Mercedes R Carnethon, Jorge R Kizer, Russell P Tracy, Nicholas L Smith, David S Siscovick.   

Abstract

BACKGROUND AND
PURPOSE: Few studies have assessed post-glucose load measures of insulin resistance and ischemic stroke risk, and data are sparse for older adults. We investigated whether fasting and post-glucose load measures of insulin resistance were related to incident ischemic stroke in nondiabetic, older adults.
METHODS: Participants were men and women in the Cardiovascular Health Study, age 65+ years and without prevalent diabetes or stroke at baseline, followed for 17 years for incident ischemic stroke. The Gutt insulin sensitivity index was calculated from baseline body weight and from fasting and 2-hour postload insulin and glucose; a lower Gutt index indicates higher insulin resistance.
RESULTS: Analyses included 3442 participants (42% men) with a mean age of 73 years. Incidence of ischemic stroke was 9.8 strokes per 1000 person-years. The relative risk (RR) for lowest quartile versus highest quartile of Gutt index was 1.64 (95% CI, 1.24-2.16), adjusted for demographics and prevalent cardiovascular and kidney disease. Similarly, the adjusted RR for highest quartile versus lowest quartile of 2-hour glucose was 1.84 (95% CI, 1.39-2.42). In contrast, the adjusted RR for highest quartile versus lowest quartile of fasting insulin was 1.10 (95% CI, 0.84-1.46).
CONCLUSIONS: In nondiabetic, older adults, insulin resistance measured by Gutt index or 2-hour glucose, but not by fasting insulin, was associated with risk of incident ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998054      PMCID: PMC3226936          DOI: 10.1161/STROKEAHA.111.620773

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study.

Authors:  Nicholas L Smith; Joshua I Barzilay; Douglas Shaffer; Peter J Savage; Susan R Heckbert; Lewis H Kuller; Richard A Kronmal; Helaine E Resnick; Bruce M Psaty
Journal:  Arch Intern Med       Date:  2002-01-28

2.  Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study).

Authors:  Laura J Rasmussen-Torvik; Hiroshi Yatsuya; Elizabeth Selvin; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2010-05-15       Impact factor: 2.778

3.  Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.

Authors:  M Gutt; C L Davis; S B Spitzer; M M Llabre; M Kumar; E M Czarnecki; N Schneiderman; J S Skyler; J B Marks
Journal:  Diabetes Res Clin Pract       Date:  2000-03       Impact factor: 5.602

4.  Exercise intensity and subclinical cardiovascular disease in the elderly. The Cardiovascular Health Study.

Authors:  D S Siscovick; L Fried; M Mittelmark; G Rutan; D Bild; D H O'Leary
Journal:  Am J Epidemiol       Date:  1997-06-01       Impact factor: 4.897

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study.

Authors:  W T Longstreth; C Bernick; A Fitzpatrick; M Cushman; L Knepper; J Lima; C D Furberg
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

Review 7.  Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies.

Authors:  Nadeem Sarwar; Naveed Sattar; Vilmundur Gudnason; John Danesh
Journal:  Eur Heart J       Date:  2007-05-17       Impact factor: 29.983

Review 8.  Insulin resistance and risk for stroke.

Authors:  W N Kernan; S E Inzucchi; C M Viscoli; L M Brass; D M Bravata; R I Horwitz
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study.

Authors:  Tatjana Rundek; Hannah Gardener; Qiang Xu; Ronald B Goldberg; Clinton B Wright; Bernadette Boden-Albala; Norbelina Disla; Myunghee C Paik; Mitchell S V Elkind; Ralph L Sacco
Journal:  Arch Neurol       Date:  2010-10
View more
  20 in total

1.  FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation.

Authors:  M El Assar; J M Sánchez-Puelles; I Royo; E López-Hernández; A Sánchez-Ferrer; J L Aceña; L Rodríguez-Mañas; J Angulo
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Insulin resistance: Is it time for primary prevention?

Authors:  Valentina Mercurio; Guido Carlomagno; Valeria Fazio; Serafino Fazio
Journal:  World J Cardiol       Date:  2012-01-26

Review 3.  Insulin resistance in ischemic stroke.

Authors:  Xiao-Ling Deng; Zhou Liu; Chuanling Wang; Yanfeng Li; Zhiyou Cai
Journal:  Metab Brain Dis       Date:  2017-06-21       Impact factor: 3.584

Review 4.  The diagnosis and management of cerebrovascular disease in diabetes.

Authors:  Michael S Phipps; Ania M Jastreboff; Karen Furie; Walter N Kernan
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

5.  Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Luc Djousse; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; George L King; Ken J Mukamal
Journal:  Metabolism       Date:  2015-07-21       Impact factor: 8.694

6.  Racial differences in the association of insulin resistance with stroke risk: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  George Howard; Lynne E Wagenknecht; Walter N Kernan; Mary Cushman; Evan L Thacker; Suzanne E Judd; Virginia J Howard; Brett M Kissela
Journal:  Stroke       Date:  2014-06-26       Impact factor: 7.914

7.  Association between physical performance and all-cause mortality in CKD.

Authors:  Baback Roshanravan; Cassianne Robinson-Cohen; Kushang V Patel; Ernest Ayers; Alyson J Littman; Ian H de Boer; T Alp Ikizler; Jonathan Himmelfarb; Leslie I Katzel; Bryan Kestenbaum; Stephen Seliger
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

8.  Fasting and post-glucose load measures of insulin resistance and risk of incident atrial fibrillation: The Cardiovascular Health Study.

Authors:  P K Garg; M L Biggs; R Kaplan; J R Kizer; S R Heckbert; K J Mukamal
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-03-02       Impact factor: 4.222

Review 9.  Diabetes mellitus and dementia.

Authors:  Toshiharu Ninomiya
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 10.  The diabetic brain and cognition.

Authors:  Peter Riederer; Amos D Korczyn; Sameh S Ali; Ovidiu Bajenaru; Mun Seong Choi; Michael Chopp; Vesna Dermanovic-Dobrota; Edna Grünblatt; Kurt A Jellinger; Mohammad Amjad Kamal; Warda Kamal; Jerzy Leszek; Tanja Maria Sheldrick-Michel; Gohar Mushtaq; Bernard Meglic; Rachel Natovich; Zvezdan Pirtosek; Martin Rakusa; Melita Salkovic-Petrisic; Reinhold Schmidt; Angelika Schmitt; G Ramachandra Sridhar; László Vécsei; Zyta Beata Wojszel; Hakan Yaman; Zheng G Zhang; Tali Cukierman-Yaffe
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.